HSP90B1 and sarcoma: However, immunisation with gp96 elicited sarcoma-specific immunity and gp96 purified from other chemically induced tumours or normal tissue did not elicit immunoprotection although no differences were observed at a protein or genetic level for these HSPs [67, 68].